Skip to content
Adamas Biotech Srl logo

Adamas Biotech Srl Alternatives & Competitors

12 companies similar to Adamas Biotech Srl — Advancing the state-of-the-art in nature-based healthcare solutions

Companies similar to Adamas Biotech Srl

Sundyota Numandis Group of Companies logo — alternative to Adamas Biotech Srl

Sundyota Numandis Group of Companies

Happy Humans on Healthy Earth

Smith+Nephew logo — alternative to Adamas Biotech Srl

Smith+Nephew

We design and manufacture technology that takes the limits off living.

SolasCure logo — alternative to Adamas Biotech Srl

SolasCure

Transforming chronic wound care with a breakthrough wound therapeutic

Eevia Health logo — alternative to Adamas Biotech Srl

Eevia Health

Bioactive extracts from Arctic plants from the Heart of Nordics🌿

Rival Readout

Competing with Adamas Biotech Srl? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
PetMedix logo — alternative to Adamas Biotech Srl

PetMedix

R&D stage veterinary therapeutics biotechnology company based in Cambridge, UK

Sai Life Sciences Ltd logo — alternative to Adamas Biotech Srl

Sai Life Sciences Ltd

Full-service CRO-CDMO with a vision to propel the launch of 25 new medicines by 2025.

CORONA Remedies Limited (formerly known as CORONA Remedies Private Limited) logo — alternative to Adamas Biotech Srl

CORONA Remedies Limited (formerly known as CORONA Remedies Private Limited)

Good Health For All & Innovation As Core Spirit

Mithra logo — alternative to Adamas Biotech Srl

Mithra

Transforming Women’s Health Through Innovation

Medisyn Technologies logo — alternative to Adamas Biotech Srl
Nerhadou International logo — alternative to Adamas Biotech Srl

Nerhadou International

To improve the health and lives.

Cosmo Pharmaceuticals logo — alternative to Adamas Biotech Srl

Cosmo Pharmaceuticals

We develop innovative treatments that address significant unmet clinical needs

Olema Oncology logo — alternative to Adamas Biotech Srl

About Adamas Biotech Srl

Adamas Biotech Srl is a clinical stage company based in Italy, founded in 2018. The company is dedicated to advancing the state-of-the-art in nature-based healthcare solutions. Specializing in the development of bioactive molecules derived from botanicals, particularly green tea catechins, Adamas Biotech is pioneering...

Business keywords

Biotech, Nutraceuticals, Clinical Stage Company, Green Tea Catechins, Cancer Prevention, Anti-aging, Wound Care, Sports Medicine, Evidence-based Medicine, Scientific Methods, Antioxidant, Anti-angiogenic, Anti-inflammatory, Botanical-derived Compounds, Prophylactic And Therapeutic Solutions

Frequently Asked Questions

Companies similar to Adamas Biotech Srl include Sundyota Numandis Group of Companies, Smith+Nephew, SolasCure, Eevia Health, PetMedix. They work in Biotechnology and Health Care and share Adamas Biotech Srl's focus on nutraceuticals, biotech and evidence-based medicine.
Bounce Watch lists 12 companies that share Adamas Biotech Srl's industries and are closest to it in business tags, services, target customers, business model and size.
Adamas Biotech Srl is a clinical stage company based in Italy, founded in 2018. The company is dedicated to advancing the state-of-the-art in nature-based healthcare solutions. Specializing in the development of bioactive molecules derived from botanicals, particularly green tea catechins, Adamas Biotech is pioneering...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Adamas Biotech Srl: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Adamas Biotech Srl on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout